AI Business LensTHE BUSINESS OF AI, FOR PEOPLE WHO TEACH IT OR LEARN FROM IT
Medical Xpress · September 12, 2026

AI virtual cell uses protein dynamics to predict personalized breast cancer treatments

MedicineBiologyBiomedical Engineering
THE AI ANGLE
Simulating dynamic cellular responses to predict drug efficacy and resistance

Researchers developed ProteinTalks, an AI virtual cell trained on over 38 million time-resolved protein measurements to simulate dynamic cellular responses to anticancer drugs. By tracking protein trajectory changes over 6 to 48 hours rather than relying on static genetic snapshots, the model outperformed existing AI approaches, accurately predicting drug sensitivities, identifying synergistic combinations for triple-negative breast cancer, and pinpointing resistance drivers like AKR1C3. This demonstrates a path forward for biomedical engineering and medicine to computationally screen therapies and tailor patient-specific treatments before conducting costly lab trials.

THE TEACHING ANGLE
Instructors can explore the mechanistic and computational advantages of modeling dynamic, time-resolved proteomic shifts versus relying on static, single-snapshot genomic profiles to predict drug efficacy and resistance.

Read the original at medicalxpress.com   Generate teaching or study materials

Instructors get discussion guides, assignments, and mini-cases. Students and readers get a plain summary, class prep, and an exercise. All built from the full article. Three are free with an account.

More in Medicine